Clinical Trials
Sponsor:
Sponsor Study ID:
Study Title:
Phase III Randomized Trial of Immunotherapy with or without Consolidative Radiotherapy for Oligometastatic Head and Neck Squamous Cell Carcinoma
NCT Number:
NCT05721755
Phase:
III
Protocol Type:
Treatment
Age Group:
Adults
Disease Sites:
Lip, Oral Cavity and Pharynx
Study Objectives:
To compare overall survival (OS) between immunotherapy plus consolidative radiotherapy (CoRT) and immunotherapy alone following non-progression with systemic chemoimmunotherapy.
Study Documents
(MUSC NetID required for document access)